amlodipine + valsartan+ hydrochlorothiazide polpharma 5 mg + 160 mg + 12,5 mg tabletki powlekane
zakłady farmaceutyczne polpharma s.a. - amlodipinum + valsartanum + hydrochlorothiazidum - tabletki powlekane - 5 mg + 160 mg + 12,5 mg
amlodipine + valsartan+ hydrochlorothiazide polpharma 10 mg + 160 mg + 12,5 mg tabletki powlekane
zakłady farmaceutyczne polpharma s.a. - amlodipinum + valsartanum + hydrochlorothiazidum - tabletki powlekane - 10 mg + 160 mg + 12,5 mg
amlodipine + valsartan+ hydrochlorothiazide polpharma 10 mg + 320 mg + 25 mg tabletki powlekane
zakłady farmaceutyczne polpharma s.a. - amlodipinum + valsartanum + hydrochlorothiazidum - tabletki powlekane - 10 mg + 320 mg + 25 mg
oxbryta
pfizer europe ma eeig - voxelotor - anemia; anemia, hemolytic; anemia, sickle cell - other hematological agents - oxbryta is indicated for the treatment of haemolytic anaemia due to sickle cell disease (scd) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide.
novidin 400 mg tabletki powlekane
gebro pharma gmbh - hydroxychloroquini sulphas - tabletki powlekane - 400 mg